StopDown
SwishX logo
Launch · 12 May 2026SwishXAgentic AI for pharma and medtechswishx.com ↗

SwishX launches agentic AI platform for pharma

By · Editor ·

seed
  • SwishX builds agentic AI to automate sales, marketing, tender management and hospital contracts for pharma and medtech
  • It launched the platform and raised a $2.2 million seed round from Powerhouse Ventures, Blume Ventures, Sadev Ventures and Atrium Ventures
  • The company pivoted from IT asset management (Swish Club) and now targets $5 million ARR and 100+ enterprise clients by end FY 2026-27

What happened

  • SwishX launched the world's first agentic AI platform for pharma and medtech on 12 May 2026.
  • The platform automates sales, marketing, distribution, tender management, hospital rate contracts and commercial workflows.
  • It raised a $2.2 million seed round from Powerhouse Ventures, Blume Ventures, Sadev Ventures and Atrium Ventures.
  • The company was formerly Swish Club, an IT asset management platform, and rebranded to SwishX after pivoting.
  • As Swish Club, it had raised $4.5 million in previous funding.
  • During the transition, SwishX let go of sales teams and ramped up engineering.
  • The platform includes four products: Tender IQ, Contract IQ, Marketing IQ and Channel IQ.
  • SwishX plans to raise a larger funding round in the future.

Why it matters

  • Pharma commercial decisions currently rely on spreadsheets, disconnected software and manual workflows, causing delayed reporting.
  • India is the 'pharmacy of the world', supplying 20% of global medicines and exporting to over 200 countries.
  • The emerging markets plus India pharma and medtech opportunity is $400 billion, growing to $770 billion by 2033 at a CAGR over 12%.
  • AI in healthcare and life sciences globally is valued at $60-110 billion annually.
  • The pivot from IT asset management was driven by capital intensity and difficulty scaling beyond India.

The business

  • SwishX builds agentic AI that captures siloed data, automates workflows, learns decision nuances and builds functional memory.
  • It positions itself as a 'system of action', not a 'system of record'.
  • Tender IQ automates tender and RFP analysis, evaluating thousands of tenders and identifying high-probability wins.
  • It analyzes documents exceeding 500 pages, recommends pricing and drafts proposals in minutes.
  • Contract IQ automates hospital rate contract management and reduces price leakage by 15%.
  • Marketing IQ converts marketing PDFs into personalized video reels for doctors, reducing production time from weeks to one day.
  • It has a database of over 8,00,000 verified doctors and increased brand visibility by 32% within six months.
  • Channel IQ provides real-time visibility into secondary sales, stockist ordering patterns and distributor compliance.
  • The platform is ISO 27001 certified, SOC 2 Type 2 compliant and GDPR-aligned, with data encrypted in transit and rest.
  • It embeds UCPMP and Section 194R compliance in marketing workflows and keeps a human-in-the-loop for final decisions.
  • Pricing is SaaS subscription-based, with individual modules, free trials and pilot programmes.
  • SwishX currently has 39 enterprise customers, 12 with annual revenue over ₹1,000 crore.
  • Its long-term vision is a vertically integrated AI for the life sciences value chain, including drug discovery and biosimilar development.

The founders

Dushyant Sapre

CEO
  • Ex-Google.
  • Founder and CEO of SwishX.

Jai Anand

Cofounder
  • Ex-Amazon.
  • Cofounder of SwishX.

Who put in money

In numbers

$2.2 millionSeed round · 2026
$4.5 millionPrevious funding (as Swish Club)
$1 millionCurrent ARR · 2026
$5 millionTarget contracted ARR · FY 2026-27
100+Target enterprise clients · FY 2026-27
39Enterprise customers · 2026
12Customers with revenue over ₹1,000 crore · 2026
8,00,000+Doctor database · 2026
three-foldTender business increase (Tender IQ) · within 3 months
80%Manual effort reduction
93%Pricing accuracy (tender analysis)
zeroMissed clauses
32%Brand visibility increase (Marketing IQ) · within 6 months
3-5 timesCampaign conversion rate increase (Marketing IQ)
15%Price leakage reduction (Contract IQ)
15-25%Revenue leakage from poor visibility
120-150 hoursManual tender processing time
up to 30%Revenue improvement potential
1.2 million+India pharmacies
~100,000US pharmacies
30-60%Procurement through government tenders
$400 billionEmerging markets + India pharma opportunity
$770 billionProjected opportunity by 2033
$60-110 billionGlobal AI value in healthcare and life sciences

What happens next

  • SwishX plans to expand into Latin America, Southeast Asia, Middle East, Africa and Eastern Europe.
  • It aims to reach $5 million contracted ARR and 100+ enterprise clients by end FY 2026-27.
  • The company plans to raise a larger funding round in the future.

Earlier rounds

  • previous (as Swish Club) · $4.5 million

Words to know

Agentic AI
Artificial intelligence that can act autonomously to perform tasks, make decisions and learn from outcomes, rather than just providing information.
ARR
Annual Recurring Revenue, a measure of the predictable revenue a subscription-based business expects each year.
Tender
A formal offer to supply goods or services at a stated price, often used by governments and large organizations for procurement.
UCPMP
Uniform Code for Pharmaceutical Marketing Practices, a set of ethical guidelines for pharmaceutical marketing in India.

The numbers around it

Enterprise Software & IT in May 2026: 7 rounds with a disclosed amount, $79.8 million in all; the biggest was Safe Security ($70 Mn). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
  • ARR and MRR: MRR is the monthly recurring revenue a company expects from subscriptions, and ARR is that figure times twelve. They suit software and subscription companies only. ARR is a run rate, not booked revenue, so ARR claims in Indian news can differ from filed accounts.

Everything on SwishX → · All startup news on 12 May 2026 →

Is this SwishX? Get your “Featured on StopDown” badge →